NDC 69238-2125-07 - Metformin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69238-2125
- Requested NDC
- 69238-2125-07
- Package NDCs from labels
- 69238-2125-3, 69238-2125-9, 69238-2125-1, 69238-2125-5, 69238-2125-7, 69238-2125-07
- Manufacturer
- Amneal Pharmaceuticals LLC
- Effective date
- 2026-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin Hydrochloride - Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals LLC | 2026-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Metformin Hydrochloride - AvKARE | AvKARE | 2026-05-13 | HUMAN PRESCRIPTION DRUG LABEL |
| Metformin Hydrochloride - AvKARE | AvKARE | 2026-05-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69238-2125-1 | Metformin Hydrochloride | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 5 | |
| 69238-2125-3 | Metformin Hydrochloride | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 5 | |
| 69238-2125-5 | Metformin Hydrochloride | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | 5 | |
| 69238-2125-7 | Metformin Hydrochloride | 1000 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 1000 | 5 | |
| 69238-2125-9 | Metformin Hydrochloride | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69238-2125 | METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS NY LLC] | 4 | Current NDC, Legacy NDC, 5 package rows | 20231128_dc65065b-cba0-46d7-8fb5-3368f3210b4d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin Hydrochloride | METFORMIN | Mylan Pharmaceuticals Inc. | 7e41818c-60e9-4bcf-9586-7bb8d33d5e89 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin HCl | METFORMIN HCL | REMEDYREPACK INC. | ded33248-44ef-45f6-a461-24b35772a1b2 | 2026-09-11 | Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | d5228e81-9c86-4781-b984-20feaa2ae779 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin | METFORMIN ER 500 MG | REMEDYREPACK INC. | 05999192-ebc6-4198-bd1e-f46abbfb4f8a | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 860975 786Z46389E |
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | 2a84c550-aed8-4058-961f-351a5e4cf7a1 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 7cc02a26-5c22-445b-ad8f-3e7570c143d3 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | e6957674-86c1-4536-8e23-54ad7f2cacc4 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | Ajanta Pharma USA Inc. | 1ed9dde4-339c-486f-a346-dde33a5e493f | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | 1200ea71-8a9e-4e49-bb77-7d9fe0d84ae7 | 2026-09-07 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | Ajanta Pharma USA Inc. | 6d9179a8-9579-4804-a4c7-633f37aef1ee | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Granules India Ltd | 73197cb5-3e23-4ac0-b189-f9bc848bce66 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | b6d7edc9-93d6-4480-906d-55c18d053600 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Dapagliflozin and Metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 513bdf9f-774c-4f7f-935a-54d3885e80a4 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Glumetza | METFORMIN HYDROCHLORIDE | Santarus, Inc. | fb832474-88d9-4e29-95cd-fbc446944cc4 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Pioglitazone Hydrochloride and Metformin Hydrochloride | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 1fa2703e-fb73-44d5-aaa2-b12b1090d42c | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Proficient Rx LP | d8bd1779-d1c4-4dde-816d-ea72b37bb5cd | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Pioglitazone HCL and Metformin HCL | PIOGLITAZONE HCL AND METFORMIN HCL | Torrent Pharmaceuticals Limited | 237d8fa2-633c-4c29-84d3-f1b413610dc3 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 64f5b140-7ad8-4c07-bbfc-ae4618afa850 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.